Virology Market worth US$ 3.7 Billion 2030 with a CAGR of 9.9%

 


The report "Virology Market, By Product Type (DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests), By Viral Infection Controlling Method (Immunoprophylaxis, Active Prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, and Immunomodulators), and Interferons), By Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, and Perinatal Infections), By End-User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies), and Region - Global Forecast to 2029" Global virology market is projected to grow from US$ 1.9 billion in 2020 to US$ 3.7 billion by 2030. Increasing outbreaks of viral infectious diseases across the globe is driving the global virology market. In addition, increasing public awareness program across the globe on Flu, Zika virus, STDs, AIDS, and Ebola virus is expected to propel the global virology market.

Key Market Insights from the report:          

The global virology market accounted for US$ 1.9 billion in 2020 and is projected to register a moderate CAGR of 9.9% over the forecast period. The market report has been segmented on the basis of product type, viral infection controlling method, application, end-user, and region.

  • By product type, the global virology market is categorized into DNA viruses, RNA viruses, prions diagnostic test, and other viral tests
  • By viral infection controlling method, Immunoprophylaxis therapy and antiviral drugs segments are accounted for fastest growing segment in the global virology market.
  • By application, urinary tract infections, and respiratory tract infections application segment is dominated in the global virology market.
  • By end-user, the hospitals and laboratories segment is accounted for major revenue share in the global virology market.
  • By region, North America virology market is expected to account for largest share in terms of revenue in the global virology market over the forecast period. This is attributed to technological advancements such as the increasing rapid and portable diagnostics in countries such as U.S. of the region. Europe virology market is expected to account for second-highest share in terms of revenue in the global virology market in the near future.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Virology Market, By Product Type (DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests), By Viral Infection Controlling Method (Immunoprophylaxis, Active Prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, and Immunomodulators), and Interferons), By Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, and Perinatal Infections), By End-User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029

To know the upcoming trends and insights prevalent in this market, click the link below

Links:

https://www.prophecymarketinsights.com/market_insight/Global-Virology-Market-By-Product-743

The prominent player operating in the global virology market includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merk KGaA, Novartis AG, AbbVie Inc, Johnson & Johnson, AstraZeneca plc, ‎ Fritz Hoffmann-La Roche, and Abivax SA.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Eggshell Membrane Market – with Chockfull Opportunities for Investors from 2019 to 2029.

Image
The eggshell membrane market accounted for US$94.7 Million in 2019 and is estimated to be US$247.9 Million by 2029 and is anticipated to register a CAGR of 10.1%. The report " Eggshell Membrane Market , By Type (Hydrolyzed and Unhydrolyzed), By Application (Nutraceuticals, Food & beverages, Cosmetics & Personal Care Products, Pharmaceuticals, and Other Applications), By Product (Capsule, Tablet, Powder, and Other Products), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2020, Stratum Nutrition’s natural eggshell membrane has received confirmation in a new independent study that it can reduce joint pain and stiffness in patients with grade 2 and 3 osteoarthritis knee (OA). The new statistics show that the ingredient made from upcycled eggshell membranes can take effect within seven to ten days, with clinically meaningful benefits persisting for 90 day...
Read more

Hydroxychloroquine Market is estimated to be US$ 2.7 Billion by 2029 with a CAGR of 5.3% during the forecasted period.

Image
H ydroxychloroquine   market accounted for US$ 1.6 billion in 2019 and is estimated to be US$ 2.7 billion by 2029 and is anticipated to register a CAGR of 5.3% Global hydroxychloroquine market size is expected to register growth over the forecast period to its applications in the pharmaceutical sector. The drug is used for treating and preventing malaria which is caused by mosquito bite. It is also used in the treatment of autoimmune diseases including lupus and rheumatoid arthritis. Recently, hydroxychloroquine is being studied for the treatment of coronavirus spread which will boost the overall market growth. The report  " Global   Hydroxychloroquine Market, By  Disease Type (Coronavirus Disease (COVID-19), Malaria, Q Fever, Rheumatoid Arthritis, Lupus Erythematosus, Porphyria Cutanea Tarda (PCT), and Other Disease Types), By Distribution Channel (Specialty Drug Store, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Eu...
Read more

Atherectomy Devices Market is estimated to be US$ 1207.81 million by 2030 with a CAGR of 8.4% during the forecast period.

Image
Atherectomy devices were developed to permit drilling, grinding, or sanding of atheroma, calcium, and excess cellular material from the site of coronary occlusion or stenosis. Both mechanical and laser-based approaches are used. It is a minimally invasive procedure similar to angioplasty. It is performed to cut away plaque that has built up in the arteries. After the plaque is removed, a stent may be placed to keep the artery open. The continuous rise in the artery blockage in the geriatric population and the cardiovascular diseases give rise to number of atherectomy procedures hence increasing the target market. As the atherectomy procedure is easy, less infectious and has a minimal surgery procedure and complications, it is more preferred over the surgical procedures. Region Analysis: In this target market, North America has the largest share in the global atherectomy device market followed by other regions. This can be attributed to high prevalence of the peripheral and coronary ar...
Read more